APX Acquisition Corp. I & Bioceres Group Announce Letter of Intent for a Business Combination with a Precision Medicine Diagnostic and Wellness Services Company

APX Acquisition Corp. I (NASDAQ: APXI) (“Company”), a publicly traded special purpose acquisition company, announces that it has signed a non-binding letter of intent (“LOI”) for a proposed business combination (the “Business Combination”) with a precision medicine company that offers genomic diagnostic tests in clinical genomics, oncology, human microbiome and reproductive genomics, as well as a digital nutrition-based DNA and gut microbiome wellness service that promotes wellbeing and prevents disease (“Target”), that would result in a public listing of the combined company upon completion of the proposed Business Combination.

Read the full article: APX Acquisition Corp. I & Bioceres Group Announce Letter of Intent for a Business Combination with a Precision Medicine Diagnostic and Wellness Services Company //

Source: https://www.prnewswire.com/news-releases/apx-acquisition-corp-i–bioceres-group-announce-letter-of-intent-for-a-business-combination-with-a-precision-medicine-diagnostic-and-wellness-services-company-302003770.html

Leave a Comment

Your email address will not be published.

Scroll to Top